Staphylococcal toxic shock syndrome, superantigenicity, and hypersensitivity.
Landman
G W D
GW
Groeneveld
P H
PH
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000276:immunology*; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D012772:Shock, Septic / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D018089:Superantigens / Q000276:immunology*
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D016756:Immunoglobulins, Intravenous; D018089:Superantigens; D002981:Clindamycin